Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.29 – $0.78
3% from low
Exchange
OTC Link
OS
Borrow rate
13.64%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $13.8K | $0 | $72.4K |
| Gross profit | $0 | $0 | $0 | $0 | −$13.8K | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $0 | $433.5K | $1.2M | $3.8M | $3.6M | $3.9M | $802.8K |
| Operating income | −$42.0K | −$673.2K | −$2.9M | −$7.3M | −$6.5M | −$12.7M | −$3.0M |
| EBITDA | $0 | $0 | $0 | $0 | −$6.5M | −$12.7M | −$2.9M |
| Net income | −$1.9K | −$673.2K | −$2.9M | −$7.3M | −$6.8M | −$13.2M | −$4.0M |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -0.00 | -0.02 | -0.11 | -0.20 | -0.17 | -0.30 | -0.05 |
Annual figures · source: Financial Modeling Prep
DEFENCE THERAPEUTICS A
No one on the platform currently holds DTCFF.
No tracked institution reports a position in DTCFF as of their last filing.
No one on the platform has traded DTCFF yet.
| $14M |
| — |
| MBXBFMicrobix Biosystems Inc. | $0.21 | +0.00% | $29M | — |
| MMIRFMedMira Inc. | $0.05 | +0.00% | $34M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.